Literature DB >> 30230610

A novel predictive model of outcome in acute myeloid leukemia without favorable karyotype based on treatment strategy, karyotype and FLT3-ITD mutational status.

Kebede H Begna1, Walid Ali1, Naseema Gangat1, Michelle A Elliott1, Aref Al-Kali1, Mark R Litzow1, C Christopher Hook1, Alexandra P Wolanskyj1, William J Hogan1, Mrinal M Patnaik1, Animesh Pardanani1, Darci L Zblewski1, Dong Chen2, Rong He2, David Viswanatha2, Curtis A Hanson2, Rhett P Ketterling3, Ayalew Tefferi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30230610     DOI： 10.1002/ajh.25290

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  2 in total

1.  Mayo Clinic experience with 1123 adults with acute myeloid leukemia.

Authors:  Kebede H Begna; Walid Ali; Michelle A Elliott; Aref Al-Kali; Mark R Litzow; C Christopher Hook; Alexandra P Wolanskyj-Spinner; William J Hogan; Mrinal M Patnaik; Animesh Pardanani; Darci L Zblewski; Dong Chen; Rong He; David Viswanatha; Curtis A Hanson; Rhett P Ketterling; Ayalew Tefferi
Journal:  Blood Cancer J       Date:  2021-03-02       Impact factor: 11.037

2.  Gilteritinib induces PUMA-dependent apoptotic cell death via AKT/GSK-3β/NF-κB pathway in colorectal cancer cells.

Authors:  Liangjun Li; Lin Lin; Ming Li; Weiling Li
Journal:  J Cell Mol Med       Date:  2019-12-27       Impact factor: 5.310
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.